Article
Inhibition of insulin‐like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival
Hepatology Communications
(2018)
Publication Date
June 1, 2018
DOI
10.1002/hep4.1181
Citation Information
Fang Wang, Thomas Bank, Gregory Malnassy, Maribel Arteaga, et al.. "Inhibition of insulin‐like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival" Hepatology Communications Vol. 2 Iss. 6 (2018) p. 732 - 746 Available at: http://works.bepress.com/peter-breslin/8/